Search research articles
Contact Us
Filters
Showing results (161-170 of 210) with videos related to
Page
of 21
Sort By:
International Journal of Cancer
|
May 30, 2009
Rimonabant inhibits human colon cancer cell growth and reduces the formation of precancerous lesions in the mouse colon
Antonietta Santoro, Simona Pisanti, Claudia Grimaldi, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
March 2, 2006
N6-isopentenyladenosine arrests tumor cell proliferation by inhibiting farnesyl diphosphate synthase and protein prenylation
Chiara Laezza, Maria Notarnicola, Maria Gabriella Caruso, et al.
International Journal of Molecular Sciences
|
August 10, 2017
Immuno-Modulatory and Anti-Inflammatory Effects of Dihydrogracilin A, a Terpene Derived from the Marine Sponge Dendrilla membranosa
Elena Ciaglia, Anna Maria Malfitano, Chiara Laezza, et al.
Oncology
|
February 17, 2005
Higher farnesyl diphosphate synthase activity in human colorectal cancer inhibition of cellular apoptosis
Maria Notarnicola, Caterina Messa, Aldo Cavallini, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 27, 2006
Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma
Alessia Ligresti, Aniello Schiano Moriello, Katarzyna Starowicz, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
October 2, 2013
Immune-modulation and properties of absorption and blood brain barrier permeability of 1,8-naphthyridine derivatives
Anna Maria Malfitano, Chiara Laezza, Giuseppe Saccomanni, et al.
Endocrine-Related Cancer
|
March 23, 2010
Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity and of Ras farnesylation mediate antitumor effects of anandamide in human breast cancer cells
Chiara Laezza, Anna Maria Malfitano, Maria Chiara Proto, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
November 23, 2013
Antiangiogenic effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, mediated by AMPK activation
Simona Pisanti, Paola Picardi, Elena Ciaglia, et al.
European Journal of Pharmacology
|
January 28, 2004
In vivo pharmacological actions of two novel inhibitors of anandamide cellular uptake
Eva de Lago, Alessia Ligresti, Giorgio Ortar, et al.
Plos One
|
May 10, 2013
Effects on immune cells of a new 1,8-naphthyridin-2-one derivative and its analogues as selective CB2 agonists: implications in multiple sclerosis
Anna Maria Malfitano, Chiara Laezza, Alba D'Alessandro, et al.
Page
of 21
Search research articles
Search
Showing results (161-170 of 210) with videos related to
Sort By:
Page
of 21
International Journal of Cancer
|
May 30, 2009
Rimonabant inhibits human colon cancer cell growth and reduces the formation of precancerous lesions in the mouse colon
Antonietta Santoro, Simona Pisanti, Claudia Grimaldi, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
March 2, 2006
N6-isopentenyladenosine arrests tumor cell proliferation by inhibiting farnesyl diphosphate synthase and protein prenylation
Chiara Laezza, Maria Notarnicola, Maria Gabriella Caruso, et al.
International Journal of Molecular Sciences
|
August 10, 2017
Immuno-Modulatory and Anti-Inflammatory Effects of Dihydrogracilin A, a Terpene Derived from the Marine Sponge Dendrilla membranosa
Elena Ciaglia, Anna Maria Malfitano, Chiara Laezza, et al.
Oncology
|
February 17, 2005
Higher farnesyl diphosphate synthase activity in human colorectal cancer inhibition of cellular apoptosis
Maria Notarnicola, Caterina Messa, Aldo Cavallini, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 27, 2006
Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma
Alessia Ligresti, Aniello Schiano Moriello, Katarzyna Starowicz, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
October 2, 2013
Immune-modulation and properties of absorption and blood brain barrier permeability of 1,8-naphthyridine derivatives
Anna Maria Malfitano, Chiara Laezza, Giuseppe Saccomanni, et al.
Endocrine-Related Cancer
|
March 23, 2010
Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity and of Ras farnesylation mediate antitumor effects of anandamide in human breast cancer cells
Chiara Laezza, Anna Maria Malfitano, Maria Chiara Proto, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
November 23, 2013
Antiangiogenic effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, mediated by AMPK activation
Simona Pisanti, Paola Picardi, Elena Ciaglia, et al.
European Journal of Pharmacology
|
January 28, 2004
In vivo pharmacological actions of two novel inhibitors of anandamide cellular uptake
Eva de Lago, Alessia Ligresti, Giorgio Ortar, et al.
Plos One
|
May 10, 2013
Effects on immune cells of a new 1,8-naphthyridin-2-one derivative and its analogues as selective CB2 agonists: implications in multiple sclerosis
Anna Maria Malfitano, Chiara Laezza, Alba D'Alessandro, et al.
Page
of 21